Musiek, Erik S
Holtzman, David M
Article History
Received: 5 November 2014
Accepted: 23 March 2015
First Online: 26 May 2015
Competing interests
: D.M.H. is a co-founder of C2N Diagnostics, LLC, a member of the scientific advisory board of C2N Diagnostics, and a consultant for Genentech, AstraZeneca, Neurophage and Eli Lilly. Washington University receives grants for the laboratory of D.M.H. from C2N Diagnostics, Eli Lilly and Janssen.